Table 4 Combined diagnoses and procedural related complications reported 3, 6 and 12 months after cryotherapy in men diagnosed with incident localized prostate cancer and no previous history of treatment. related morbidity, SEER-Medicare

From: Treatment profile and complications associated with cryotherapy for localized prostate cancer: A population-based study

Complication

3 months

6 months

12 months

 

n

%

n

%

n

%

Lower urinary tract obstructiona

78

23.7

90

27.4

94

28.7

Erectile dysfunctionb

14

4

46

13.2

70

20.1

Urinary incontinencec

14

3.8

29

7.9

36

9.8

Bowel bleedingd

<11

<2.9

<11

<2.9

12

3.3

Hydronephrosise

0

0

0

0

0

0

Urinary fistulaf

0

0

0

0

0

0

Bowel fistulag

0

0

0

0

0

0

  1. Abbreviation: SEER, Surveillance Epidemiology End Results.
  2. aLower urinary tract obstruction included medical claim of dilation, urethrotomy, urethroplasty, sphincterotomy, transurethral prostate resection/destruction, urethral stent or injection for strictureoccuring. In all, 328 men had no previous history of urinary obstruction before cryotherapy.
  3. bErectile Dysfunction included medical claim for penile prosthesis or intracavernosal. In all, 349 men had no previous history of erectile dysfunction before cryotherapy.
  4. cUrinary incontinence included a medical claim of urethra sphincter injection, artificial sphincter or incontinence repair (sling, urethroplasty) occuring. In all, 368 men had no previous history of urinary incontinence before cryotherapy.
  5. dBowel bleeding included hemorrhage or inflammation. In all, 359 men did not have bowel bleeding before cryotherapy.
  6. eHydronephrosis is distention of the renal pelvic and calices of the kidney with urine.
  7. fBowel Fistula included medical claims of rectal repair, colostomy or ulcer.
  8. gUrinary Fistula was defined as medical claims with repair of bowel-bladder fistula or closure of urethrostomy or urethrocutaneous fistula occurring.
Back to article page